|
|
| | Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine Basic information |
| Product Name: | Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine | | Synonyms: | (R)-Tofisopam;5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-, (5R)- (9CI);5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-, (R)-;Unii-ez15I5D6C1;5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-, (5R)-;Dextofisopam;Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine | | CAS: | 82059-50-5 | | MF: | C22H26N2O4 | | MW: | 382.45 | | EINECS: | | | Product Categories: | | | Mol File: | 82059-50-5.mol |  |
| | Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine Chemical Properties |
| Boiling point | 479.0±45.0 °C(Predicted) | | density | 1.15±0.1 g/cm3(Predicted) | | pka | 7.29±0.40(Predicted) |
| | Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine Usage And Synthesis |
| Uses | Treatment of irritable bowel syndrome, Crohn’s disease; anti-anxiety, anti-stress. |
| | Dextofisopam,(R)-(5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine Preparation Products And Raw materials |
|